Unknown

Dataset Information

0

IL-1?, IL-23, and TGF-? drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation.

ABSTRACT: Innate lymphoid cells (ILCs) are crucial for the immune surveillance at mucosal sites. ILCs coordinate early eradication of pathogens and contribute to tissue healing and remodeling, features that are dysfunctional in patients with cystic fibrosis (CF). The mechanisms by which ILCs contribute to CF-immunopathology are ill-defined. Here, we show that group 2 ILCs (ILC2s) transdifferentiated into IL-17-secreting cells in the presence of the epithelial-derived cytokines IL-1?, IL-23 and TGF-?. This conversion is abrogated by IL-4 or vitamin D3. IL-17 producing ILC2s induce IL-8 secretion by epithelial cells and their presence in nasal polyps of CF patients is associated with neutrophilia. Our data suggest that ILC2s undergo transdifferentiation in CF nasal polyps in response to local cytokines, which are induced by infectious agents.

SUBMITTER: Golebski K 

PROVIDER: S-EPMC6517442 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Innate lymphoid cells (ILCs) are crucial for the immune surveillance at mucosal sites. ILCs coordinate early eradication of pathogens and contribute to tissue healing and remodeling, features that are dysfunctional in patients with cystic fibrosis (CF). The mechanisms by which ILCs contribute to CF-immunopathology are ill-defined. Here, we show that group 2 ILCs (ILC2s) transdifferentiated into IL-17-secreting cells in the presence of the epithelial-derived cytokines IL-1β, IL-23 and TGF-β. This  ...[more]

Similar Datasets

Transcriptomics IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation
2019-03-26 | GSE124926 | GEO
Genomics IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation
| PRJNA514327 | ENA
Unknown Interleukin-36?-producing macrophages drive IL-17-mediated fibrosis.
| S-EPMC7549193 | biostudies-literature
Unknown IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections.
| S-EPMC2829977 | biostudies-literature
Unknown Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.
| S-EPMC3601659 | biostudies-literature
Transcriptomics Interleukin-36y-producing macrophages drive IL-17-mediated fibrosis.
2019-10-10 | GSE138027 | GEO
Unknown The Human IL-23 Decoy Receptor Inhibits T-Cells Producing IL-17 by Genetically Engineered Mesenchymal Stem Cells.
| S-EPMC6313978 | biostudies-literature
Proteomics Meningeal γδ T cells producing IL-17 control synaptic plasticity and cognitive behaviour
2019-10-16 | PXD007574 | Pride
Unknown IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.
| S-EPMC8018566 | biostudies-literature
Unknown Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells.
| S-EPMC4285857 | biostudies-literature